Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
acquisition symbols : Jspr save search
Jasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 21:00) - globenewswire.com
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: 5.76%
H: 4.44%
C: -2.2%
conference therapeutics
Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
Published: 2024-03-21 (Crawled : 21:00) - globenewswire.com
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: 1.31%
H: 0.35%
C: -2.76%
conference disease therapeutics
Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a SPOTLIGHT Clinical Study of Briquilimab in Chronic Inducible Urticaria
Published: 2024-03-19 (Crawled : 12:00) - globenewswire.com
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: -1.29%
H: 9.86%
C: 6.93%
first urticaria therapeutics study
New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia
Published: 2024-03-15 (Crawled : 12:00) - globenewswire.com
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: -0.41%
H: 5.52%
C: 3.42%
anemia positive
Jasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments
Published: 2024-03-04 (Crawled : 17:00) - biospace.com/
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: 6.79%
H: 0.0%
C: -5.51%
therapeutics financial results
Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference
Published: 2024-02-26 (Crawled : 22:00) - globenewswire.com
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: 1.3%
H: 5.45%
C: -0.19%
conference therapeutics
Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
Published: 2024-02-23 (Crawled : 13:00) - globenewswire.com
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: -0.82%
H: 7.48%
C: 5.2%
preclinical immunology meeting therapeutics
Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference
Published: 2024-02-07 (Crawled : 13:00) - globenewswire.com
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: 14.16%
H: 6.26%
C: 3.37%
conference therapeutics
Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock
Published: 2024-02-06 (Crawled : 14:00) - globenewswire.com
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: 11.04%
H: 12.56%
C: 3.13%
million offering therapeutics
Jasper Therapeutics Announces Preclinical Data Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
Published: 2024-02-05 (Crawled : 13:00) - globenewswire.com
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: 0.17%
H: 12.78%
C: 7.47%
preclinical immunology meeting therapeutics
Jasper Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-02-02 (Crawled : 13:00) - globenewswire.com
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: -0.66%
H: 0.49%
C: -0.82%
nasdaq grants
Jasper Therapeutics Highlights Recent Accomplishments and Key Upcoming Milestones
Published: 2024-01-05 (Crawled : 13:30) - globenewswire.com
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: 0.0%
H: 0.85%
C: 0.57%
therapeutics
Jasper Therapeutics, Inc. Announces Reverse Stock Split
Published: 2024-01-02 (Crawled : 13:00) - globenewswire.com
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: -13.24%
H: 3.71%
C: -0.57%
Jasper Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-12-18 (Crawled : 22:00) - globenewswire.com
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: 0.0%
H: 19.13%
C: 12.11%
nasdaq grants
Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant in Oral Presentation at ASH 2023
Published: 2023-12-10 (Crawled : 16:20) - globenewswire.com
JSPR | $22.0 -2.31% -2.36% 78K
|
| Email alert
Add to watchlist
presentation positive cell aml therapeutics results study
Jasper Announces First Patient Dosed in Phase 1b/2a Clinical Study of Briquilimab in Chronic Spontaneous Urticaria
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: 7.68%
H: 0.06%
C: -3.21%
urticaria study
Jasper Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-09 (Crawled : 13:00) - globenewswire.com
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: 1.47%
H: 0.0%
C: -9.41%
business update therapeutics financial results
Jasper Therapeutics to Participate at Upcoming Medical and Investor Conferences
Published: 2023-11-08 (Crawled : 22:00) - globenewswire.com
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: 1.47%
H: 0.0%
C: -9.41%
medical therapeutics
Jasper Therapeutics Announces Oral Presentation of Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant at ASH 2023
Published: 2023-11-02 (Crawled : 13:00) - globenewswire.com
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: -5.24%
H: 10.87%
C: 6.39%
presentation positive cell aml therapeutics results study
Jasper Therapeutics Announces Appointment of Thomas G. Wiggans as Chairperson of the Board of Directors
Published: 2023-11-01 (Crawled : 12:00) - globenewswire.com
DERM | $3.59 1.41% 1.39% 75K
|
|
| O: 3.54%
H: 1.14%
C: -1.71%
JSPR | $22.0 -2.31% -2.36% 78K
|
|
| O: 6.52%
H: 6.67%
C: -2.52%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -2.76%
H: 0.0%
C: 0.0%
CBAY | $32.48 0.03% 8.4M
|
Health Technology
|
| O: 2.63%
H: 1.52%
C: 0.0%
ANNX | $4.46 -1.87% -1.91% 800K
|
Health Technology
|
| O: 0.0%
H: 9.47%
C: 5.73%
therapeutics
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.